Evidence map›Paper›PMID 23825191›Full record

ArticleClinical and vaccine immunology : CVI2013

Immunochromatographic detection of the group B streptococcus antigen from enrichment cultures.

Hidehito Matsui, Juri Kimura, Masato Higashide, Yoshio Takeuchi, Kuniyuki Okue, Longzhu Cui, Taiji Nakae, Keisuke Sunakawa, Hideaki Hanaki

Open access · diamondAbstract readEvaluation Study
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Biology · 2024
    Review
  3. Article
  4. Colonisation of Group BBMJ open · 2023
    Article
  5. Article
  6. Diagnostic Performance of Various Methodologies for Group B SFrontiers in cellular and infection microbiology · 2021
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hidehito MatsuiResearch Center for Infections and Antimicrobials, Kitasato Institute for Life Sciences, Kitasato University, Shirokane, Minato-Ku, Tokyo, Japan.
Juri Kimura
Masato Higashide
Yoshio Takeuchi
Kuniyuki Okue
Longzhu Cui
Taiji Nakae
Keisuke Sunakawa
Hideaki Hanaki
Kitasato University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Group B Streptococcus (GBS; Streptococcus agalactiae) is a leading cause of serious neonatal infections. The Centers for Disease Control and Prevention recommends GBS screening for all pregnant women during the 35th to 37th weeks of gestation. Although GBS screening has been performed mainly by the culture-based method, it takes several days to obtain a reliable result. In this study, we developed a rapid immunochromatographic test (ICT) for the detection of GBS-specific surface immunogenic protein in 15 min using an overnight enrichment culture. The ICT was prepared using two anti-Sip monoclonal antibodies. This ICT was able to detect recombinant Sip levels of 0.5 ng/ml, or about 10(6) CFU/ml of GBS cells, in tests with 9 GBS strains of different serotypes. The cross-reactivity test using 26 species of microorganism showed no detectable false-positive result. Reactivity of the ICT with 229 GBS strains showed one false-negative result that was attributable to the production of truncated Sip. Among 260 enrichment cultures of vaginal swabs, 17 produced red to orange pigments in Granada medium, and they were all GBS and Sip positive. Among 219 pigment-negative cultures, 12 were GBS positive and 10 were Sip positive. Two Sip-negative cultures contained GBS cells below the limit of detection by the ICT. Among 207 GBS-negative cultures, only one was Sip positive, which was attributable to GBS cell debris. Thus, the sensitivity and specificity of the ICT appeared to be 93.1% and 99.6%, respectively. The newly developed ICT is readily applicable to clinical use in the detection of GBS.

Indexed as

Antibodies, BacterialAntibodies, MonoclonalAntigens, BacterialChromatography, AffinityFalse Negative ReactionsFemaleHumansMass ScreeningPregnancyPregnancy Complications, InfectiousSensitivity and SpecificityStreptococcal InfectionsStreptococcus agalactiaeTime FactorsAntibodies, BacterialAntibodies, MonoclonalAntigens, BacterialSIP protein, Streptococcus group B

Identifiers

PMID23825191
PMCPMC3889584
OpenAlexW2080602766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.